In patients with T2D and obesity, however, markedly elevated serum FGF21 levels have been observed11–14, prompting the hypothesis that obesity is a FGF21-resistant metabolic state15. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.